Victoria, Canada

Jan Burian

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Jan Burian

Introduction

Jan Burian, a prolific inventor based in Victoria, Canada, has made significant contributions to the field of biotechnology. With six patents to her name, she has been instrumental in developing new diagnostic and therapeutic techniques that leverage her expertise in protein toxins.

Latest Patents

Among her most recent inventions is a protein toxin known as exoenzyme T (AexT), which is categorized under ADP-ribosylating toxins. This innovative work showcases AexT as a novel calcium (or other cation concentration) dependent promoter. Burian's patent also outlines methods for diagnostic, preventive, and therapeutic techniques including the preparation of bacterin vaccines based on AexT, aimed at inducing immunity against various infections. Another significant patent details a newly identified and characterized type III secretion system. This invention broadens the scope of research and application by encompassing components of the novel secretion system for immunoprotection against infections as well as other diagnostic and therapeutic uses.

Career Highlights

Jan Burian's career has been marked by a strong focus on advancements in biotechnology. Her academic pursuits at the Universität Bern have allowed her to conduct research that bridges the gap between theoretical science and practical applications in healthcare. Her dedication to innovation has led her to cultivate a reputation as a leader in her field.

Collaborations

Throughout her career, Jan has collaborated with distinguished colleagues including Joachim Frey and Michael A. Kuzyk. These collaborations have facilitated the exchange of ideas and expertise essential for the advancement of her inventions, contributing to advancements in diagnostic and therapeutic technologies.

Conclusion

Jan Burian’s journey reflects a remarkable commitment to innovation in biotechnology. Her patents not only enhance our understanding of protein toxins but also demonstrate her ability to develop practical solutions that have the potential to improve health outcomes. As she continues her research, the impact of her contributions will likely resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…